TSHA - Taysha Gene Therapies  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

TSHA is currently covered by 7 analysts with an average price target of $13.6. This is a potential upside of $8.69 (176.99%) from yesterday's end of day stock price of $4.91.

Taysha Gene Therapies 's activity chart (see below) currently has 99 price targets and 115 ratings on display. The stock rating distribution of TSHA is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 24.81% with an average time for these price targets to be met of 243.81 days.

Highest price target for TSHA is $14, Lowest price target is $6, average price target is $9.86.

Most recent stock forecast was given by GIL BLUM from NEEDHAM on 16-Oct-2025. First documented stock forecast 18-Oct-2020.

Currently out of the existing stock ratings of TSHA, 22 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$10

$5.25 (110.53%)

$10

14 days ago
(16-Oct-2025)

3/22 (13.64%)

$5.28 (111.86%)

707

Buy

$12

$7.25 (152.63%)

$9

14 days ago
(16-Oct-2025)

2/8 (25%)

$7.28 (154.24%)

739

Buy

$12

$7.25 (152.63%)

$7

29 days ago
(01-Oct-2025)

0/5 (0%)

$7.12 (145.90%)

Buy

$8

$3.25 (68.42%)

$10

2 months 18 days ago
(12-Aug-2025)

0/3 (0%)

$4.97 (164.03%)

Buy

$14

$9.25 (194.74%)

$11

2 months 18 days ago
(12-Aug-2025)

0/7 (0%)

$10.97 (362.05%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is TSHA (Taysha Gene Therapies ) average time for price targets to be met?

On average it took 243.81 days on average for the stock forecasts to be realized with a an average price target met ratio 24.81

Which analyst has the current highest performing score on TSHA (Taysha Gene Therapies ) with a proven track record?

SALVEEN RICHTER

Which analyst has the most public recommendations on TSHA (Taysha Gene Therapies )?

Salveen Richter works at GOLDMAN SACHS and has 8 price targets and 6 ratings on TSHA

Which analyst is the currently most bullish on TSHA (Taysha Gene Therapies )?

Whitney Ijem with highest potential upside - $9.25

Which analyst is the currently most reserved on TSHA (Taysha Gene Therapies )?

Salveen Richter with lowest potential downside - -$1.75

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?